CFRs vary widely between countries, from 0.2% in Germany to 7.7% in Italy. But it says that this is not necessarily an a...
US confirmed cases US State Wise Explore More on North America ...
On March 18 and March 19, 2020 respectively, the European Commission and the U.S. Federal Trade Commission cleared the p...
The new Agilent GenetiSure Cyto microarrays include updated, clinically relevant content from respected databases. The p...
Mayo Clinic and Hitachi, Ltd. have reached an agreement in principle to build a carbon ion treatment facility as part of...
Graphene 3D Lab Inc. on 29 Oct 2019, announced that the US Patent Office has approved the issuance of the "Pro...
GE Healthcare Life Sciences is launching KUBio™ box, a fully-integrated, flexible, and adaptable biomanufacturing ...
Johnson & Johnson has announced that it has committed to ensuring more than $500 million is dedicated...
The U.S. Food and Drug Administration (FDA) has approved BAQSIMI™ (glucagon) nasal powder 3 mg for the treatment o...
Health Catalyst, a leading provider of data and analytics technology and services to healthcare organizations has announ...
PORT WASHINGTON, N.Y (US). – July 20, 2019 – Pall Corporation, a global leader in filtration, separati...
Philadelphia, PA (July 17, 2019) – Oncoceutics, Inc. issues this announcement on Glioblastoma Awareness Day to r...
CEL-SCI Corporation (NYSE American: CVM) announced that one of its key collaborators from Rush University Medi...
Platelet BioGenesis, the leader in stem cell-derived, on-demand human platelets (PLTs+) and platelet-based therapeu...
Synthetic Biologics, a late-stage clinical company developing therapeutics that preserve the microbiome to protect ...
Executive Women in Bio (EWIB), a committee comprised of senior leaders in the life sciences and biopharma operating with...
The 11th annual Dealmakers’ Intentions Study from Syneos Health Consulting, an industry-leading biopharmaceutical ...
The Discovery Labs, a platform company formed by MLP Ventures, announced at BIO 2019 (Booth 4134) it is redeveloping Gla...
